Sign in

CIK 0001326190

  • Non-accelerated filer
  • Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
202726770
Phone
+1 862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
  1. 4 Open-market buy Director bought 300 shares at $2.88 ($863)
  2. 4 Grant or award President and CEO acquired 126 shares (grant or award)
  3. 4 Grant or award Chief Financial Officer acquired 1,825 shares (grant or award)
  4. 4 Grant or award Chief Medical Officer acquired 691 shares (grant or award)
  5. 4 Grant or award Chief Scientific Officer acquired 568 shares (grant or award)
  6. 4 Grant or award Chief Business Officer acquired 1,832 shares (grant or award)
  7. 4 Open-market sale Director sold 2,714 shares at $15.00 ($40,710)
  8. 4 Open-market buy Director bought 9,000 shares at $4.27 ($38,430)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market buy Chief Financial Officer bought 10,000 shares at $4.31 ($43,140)
  12. 4 Open-market buy Chief Medical Officer bought 10,000 shares at $4.22 ($42,200)
  13. 4 Shares withheld for taxes Chief Scientific Officer gave up 2,375 shares (to pay taxes)
  14. 4 Shares withheld for taxes Chief Medical Officer gave up 2,364 shares (to pay taxes)
  15. 4 Shares withheld for taxes President and CEO gave up 8,422 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Scientific Officer gave up 2,183 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Medical Officer gave up 2,183 shares (to pay taxes)
  18. 4 Shares withheld for taxes President and CEO gave up 7,658 shares (to pay taxes)
  19. 4 Grant or award Chief Financial Officer acquired 1,172 shares (grant or award)
  20. 4 Derivatives Options or other derivatives

Page 7 of 34 · 674 filings